According to Wu Shuo, PR Newswire reports that the American biopharmaceutical company Hoth Therapeutics, Inc. has announced that its board of directors has approved the purchase of up to 1 million USD worth of Bitcoin. Hoth's CEO Robb Knie stated, "We believe that Bitcoin will become a powerful financial reserve asset. The anti-inflation characteristics of Bitcoin may make it a reliable asset with value storage capabilities."

<div> 

		Wu said, according to PR Newswire, that the American biopharmaceutical company Hoth Therapeutics, Inc. announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated, "We believe that Bitcoin will become a powerful financial reserve asset. Its anti-inflation characteristics may make it a reliable asset with value storage functions." 
<div> </div> </div>

Hoth Therapeutics' board approved the purchase of 1 million USD worth of Bitcoin as reserve assets.

According to BlockBeats news on November 20, Hoth Therapeutics, Inc. (NASDAQ: HOTH), a publicly traded company in the U.S., announced that its board of directors approved the purchase of $1 million worth of Bitcoin. Hoth CEO Robb Knie stated, "With the continued growth of Bitcoin and its gradual emergence as a major asset class, we believe Bitcoin will become a strong financial reserve asset and a powerful addition to our financial strategy." BlockBeats notes: Recently, several companies have expressed intentions to emulate MicroStrategy's Bitcoin strategy, treating Bitcoin as a strategic reserve asset. On November 19, Genius Group, a publicly traded company in the U.S., purchased 110 Bitcoins for $10 million to establish a Bitcoin reserve;On November 20, Chris Pavlovski, founder and CEO of the video streaming platform Rumble, initiated a poll on social media asking whether Bitcoin should be included in the company's balance sheet. Following the announcement, the company’s stock price surged by 9% in after-hours trading;On November 20, the board of directors of Acurx Pharmaceuticals, a publicly traded biopharmaceutical company, approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset.

Hoth Therapeutics, a publicly traded company on the U.S. stock market, has approved Bitcoin as a treasury reserve asset.

Hoth Therapeutics, a publicly traded company in the United States, announced that it will adopt Bitcoin as a financial reserve asset. The board of Hoth Therapeutics approved the purchase of $1 million worth of Bitcoin. CEO Robb Knie stated that the continuous growth of Bitcoin has made it a major asset class, believing that Bitcoin will serve as a strong financial reserve asset and complement the company’s financial strategy. Recently, several companies have expressed plans to follow MicroStrategy's Bitcoin strategy by adopting Bitcoin as a strategic reserve asset. Other companies such as Genius Group and Acurx Pharmaceuticals have also taken similar actions.

BlockBeats News, November 20, according to The AP News, U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that the company's board of directors has approved the purchase of $1 million worth of Bitcoin. Hoth's CEO Robb Knie stated: "With the continued growth of Bitcoin, gradually becoming a major asset class, we believe Bitcoin will be a powerful financial reserve asset and a strong complement to our financial strategy." BlockBeats Note: Recently, several companies have expressed their intention to emulate MicroStrategy's Bitcoin strategy by incorporating Bitcoin as a strategic reserve asset. On November 19, U.S. publicly traded company Genius Group bought 110 bitcoins for $10 million, establishing a Bitcoin reserve;On November 20, video streaming platform Rumble's founder and CEO Chris Pavlovski initiated a poll on social media asking whether Bitcoin should be included in the company's balance sheet. After the news was announced, the company's stock price surged 9% in after-hours trading;On November 20, the board of directors of U.S. publicly traded biopharmaceutical company Acurx Pharmaceuticals approved the purchase of up to $1 million worth of Bitcoin as a treasury reserve asset.

Hoth Therapeutics Incorporates Bitcoin into Financial Reserves

According to TechFlow, on November 20, Hoth Therapeutics, a publicly traded company in the United States, announced that its board of directors approved the purchase of up to 1 million USD in Bitcoin. Hoth's CEO Robb Knie stated, "As Bitcoin continues to grow and gradually becomes a major asset class, attracting attention and recognition from investors, we believe Bitcoin will serve as a strong financial reserve asset. With the recent approval of Bitcoin ETFs and increasing activity from institutional investors, Bitcoin will be a powerful complement to financial strategies. We believe Bitcoin's anti-inflation characteristics may make it a reliable asset with value storage capabilities."

<div>
According to a report by prnewswire on November 20, Deep Tide TechFlow announced that Hoth Therapeutics, a publicly listed company in the United States, has approved the purchase of up to 1 million USD in Bitcoin by its board of directors. Hoth's CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its gradual recognition as a major asset class attracting the attention and acknowledgment of investors, we believe Bitcoin will become a powerful financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will serve as a strong complement to financial strategies. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
</div>

The board of Hoth Therapeutics, a publicly listed company in the United States, has approved the purchase of 1 million USD worth of BTC as a reserve asset.

U.S. publicly listed company Hoth Therapeutics announced that its board of directors has approved the purchase of up to 1 million USD worth of Bitcoin. Hoth's CEO Robb Knie stated, "With the continued growth of Bitcoin and its gradual emergence as a major asset class attracting the attention and recognition of investors, we believe Bitcoin will become a powerful financial reserve asset. With the recent approval of Bitcoin ETFs and increasing activity from institutional investors, Bitcoin will serve as a strong complement to financial strategies. We believe Bitcoin's anti-inflation characteristics may make it a reliable asset with value storage capabilities." (prnewswire)

Odaily Planet Daily reported that the US-listed company Hoth Therapeutics announced that its board of directors approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated, "As Bitcoin continues to grow and gradually becomes a major asset class, attracting the attention and recognition of investors, we believe Bitcoin will serve as a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to financial strategies. We believe the anti-inflation characteristics of Bitcoin could make it a reliable asset with value storage functions." (prnewswire)

The board of directors of Hoth Therapeutics, a publicly traded company in the United States, has approved the purchase of 1 million USD worth of BTC as reserve assets.

PANews, November 20, reported by PR Newswire, that the U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its emergence as a major asset class attracting investor attention and recognition, we believe Bitcoin will become a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
According to reports, Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board of directors approved the purchase of 1 million USD in Bitcoin as a reserve asset.
PANews, November 20, reported by PR Newswire, that the U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its emergence as a major asset class attracting investor attention and recognition, we believe Bitcoin will become a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
According to reports, Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board of directors approved the purchase of 1 million USD in Bitcoin as a reserve asset.

PANews reported on November 20 that Hoth Therapeutics, Inc. (NASDAQ: HOTH), a U.S. public company, announced that its board of directors approved the purchase of up to 1 million USD worth of Bitcoin. Hoth CEO Robb Knie stated, "With the continued growth of Bitcoin, which is gradually becoming a major asset class attracting investor attention and recognition, we believe Bitcoin will serve as a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation characteristics may make it a reliable asset with value storage capabilities." 

It was reported that Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board approved the purchase of 1 million USD worth of Bitcoin as a reserve asset.

The board of directors of Hoth Therapeutics, a publicly traded company in the United States, approved the purchase of 1 million USD worth of Bitcoin as reserve assets.

Hoth Therapeutics, a biopharmaceutical company, has announced a plan to purchase $1 million worth of Bitcoin to use as a treasury reserve asset. This decision, approved by the company's Board of Directors, aligns with the growing trend of institutional interest in Bitcoin, especially following the U.S. elections. The CEO of Hoth Therapeutics, Robb Kine, highlighted Bitcoin's potential as a major asset class and its inflation-resistant characteristics, which make it a strong addition to their treasury strategy. The announcement has contributed to the overall market optimism surrounding Bitcoin, which has seen increased institutional demand and a new all-time high in its price. Additionally, the launch of Bitcoin ETF options and other market activities, such as BTC miner MARA's plan to raise $700 million for further Bitcoin purchases, have further fueled positive market sentiment.

HIGHLIGHTS Hoth Therapeutics announce plans to buy $1M worth of BTC. The firm&#039;s Board of Directors approve its plan to make Bitcoin as a strategic reserve. The chronicle underscores falls in line with rising institutional demand in the asset following the U.S. elections. In an unprecedented move, biopharmaceutical company Hoth Therapeutics announced on Wednesday that it plans to buy $1M worth of BTC, sparking market discussions globally. The company's Board of Directors approved the abovementioned purchase, primarily in an effort to strengthen the firm's treasury reserve. This announcement has further gained significant traction as the flagship crypto continues to witness soaring institutional interest post-U.S. elections.
Hoth Therapeutics Announce Bitcoin As Treasury Reserve Asset.
According to an official press release dated November 20,  Hoth Therapeutics' Board of Directors approved the purchase of $1M worth of the crypto as the firm's treasury reserve asset. Notably, Hoth Therapeutics CEO, Robb Kine, stated, "As Bitcoin continues to grow, gaining investor attention and acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset."

Kine takes the stage to further add that "With recent approval of Bitcoin ETFs and increasing activity from institutional investors, it is a strong addition to our treasury strategy. We believe its inflation-resistant characteristics may make it a reliable asset as a functional store of value."

Overall, this announcement echoed notable optimism surrounding the leading crypto by market cap, underscoring rising market demand.
Soaring Institutional Interest Propels Further Market Optimism
The flagship crypto leverages further market optimism as institutions rush to accumulate more BTC post-U.S. elections. Notably, BTC ETFs continue to record robust inflows, as seen by Bitwise hitting $10 billion in assets under management.

Primarily, this rising demand comes against the backdrop of Donald Trump's win in the U.S. elections. Trump's reelection also ignited positive sentiments around establishing a strategic U.S. Bitcoin reserve.

Furthermore, in light of the BTC ETF Options launch today, a bolstered market sentiment is much awaited by market participants. Simultaneously, the flagship crypto also hit a new ATH at the $94,600 level intraday, adding to investor optimism surrounding the asset. Coupled with Hoth Therapeutics' BTC buying plan, recent market events paint a highly optimistic scenario for the crypto.

Moreover, BTC miner MARA's plans to raise $700 million for further purchasing the coin have added to market bullishness on future movements.

Hoth Therapeutics Plans $1M Bitcoin Purchase as Treasury Reserve

Hoth Therapeutics has decided to allocate $1 million of its treasury assets to Bitcoin. This move highlights the growing trend of businesses adopting Bitcoin, particularly due to its perceived value as a hedge against inflation. The decision reflects the increasing attention and confidence in Bitcoin's potential to preserve value over time.

<img src='https://sosovalue.s3.us-west-2.amazonaws.com/sosovalue/web3image/24/11/21/9emottb2ooc5.png'/>Hoth Therapeutics allocates $1 million to Bitcoin, reflecting rising business adoption amid increasing attention on BTC’s inflation-resistant value.

Hoth Therapeutics Invests $1M in Bitcoin as Treasury Asset

Hoth Therapeutics has decided to allocate $1 million to Bitcoin as a treasury asset. This move highlights the growing trend of businesses adopting Bitcoin, particularly due to its perceived value as a hedge against inflation. The decision reflects the increasing attention and confidence in Bitcoin's potential to preserve value over time.

<img src='https://sosovalue.s3.us-west-2.amazonaws.com/sosovalue/web3image/24/11/20/3ihvtm57oot4.png'/>Hoth Therapeutics allocates $1 million to Bitcoin, reflecting rising business adoption amid increasing attention on BTC’s inflation-resistant value.

根据吴硕的报道，PR Newswire 透露，美国生物制药公司 Hoth Therapeutics, Inc. 宣布其董事会已批准购买高达 100 万美元的 Bitcoin。Hoth 的首席执行官 Robb Knie 表示：“我们相信 Bitcoin 将成为一种强大的金融储备资产。Bitcoin 的抗通胀特性可能使其成为一种可靠的价值存储资产。”

Hoth Therapeutics的董事会批准购买价值100万美元的Bitcoin作为储备资产。

根據吳碩的報道，PR Newswire 透露，美國生物制藥公司 Hoth Therapeutics, Inc. 宣佈其董事會已批准購買高達 100 萬美元的 Bitcoin。Hoth 的首席執行官 Robb Knie 表示：“我們相信 Bitcoin 將成爲一種強大的金融儲備資產。Bitcoin 的抗通脹特性可能使其成爲一種可靠的價值存儲資產。”